Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

D.G. Georganopoulou1, Lei Chang1, Jwa‐Min Nam1, C. Shad Thaxton1, Elliott J. Mufson1, William L. Klein1, Chad A. Mirkin1
1Department of Chemistry and Institute of Nanotechnology and Department of Neurobiology and Physiology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208; and Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612

Tóm tắt

The recently developed ultrasensitive bio-barcode assay was used to measure the concentration of amyloid-β-derived diffusible ligands (ADDLs), a potential soluble pathogenic Alzheimer's disease (AD) marker, in the cerebrospinal fluid (CSF) of 30 individuals. ADDL concentrations for the subjects diagnosed with AD were consistently higher than the levels in the CSF taken from nondemented age-matched controls. Studies of ADDLs or for any other potential pathogenic AD markers in CSF have not been possible because of their low concentration in CSF (<1 pM). This study is a step toward a diagnostic tool, based on soluble pathogenic markers for the debilitating disease.

Từ khóa


Tài liệu tham khảo

10.1038/nn940

Prussiner S. Rosenberg R. Di Mauro S. & Barche R. eds. (1997) The Molecular and Genetic Basis of Neurological Disease (Butterworth–Heinemann Boston) 2nd Ed.

10.1016/S0197-4580(97)00052-3

10.1056/NEJM200008173430701

Heckl, S., Pipkorn, R., Nägele, T., Vogel, U., Küker, W. & Voight, K. (2004) Histol. Histopathol. 19, 651-668.15024722

Calderón, G. P. L., Parra, R. M. A., Llibre, R. J. J. & Gutiérrez, J. V. (2004) Rev. Neurol. 38, 422-427.15029518

Oksengaard, A. R., Haakonsen, M., Dullerud, R., Engedal, K. & Laake, K. (2003) Int. J. Geriatr. Psychiatry 4, 308-312.

10.1212/WNL.56.9.1143

10.1001/archneur.60.12.1696

Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B. & Blennow, K. (2001) Arch. Neurol. 58, 373-279.11255440

10.1111/j.1365-2796.2004.01368.x

10.1016/S1474-4422(03)00530-1

10.1016/S0197-4580(01)00328-1

Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) J. Am. Med. Assoc. 289, 2094-2103.

10.1212/WNL.52.8.1555

10.1212/WNL.48.3.632

Maddalena, A., Papassotiropoulos, A., Müller-Tillmanns, B., Jung, H. H., Hegi, T., Nitsch, R. M. & Hock, C. (2003) Arch. Neurol. 60, 1202-1206.12975284

10.1126/science.1088755

10.1021/ja049384

10.1126/science.1072994

10.1038/nature02621

10.1016/j.neuron.2004.07.003

Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., Klein, W. L. (2001) J. Neurochem. 3, 595-605.

10.1021/bi030029q

10.1385/JMN:20:3:305

10.1073/pnas.1834302100

10.1021/nl049670j

10.1021/ja021096v

10.1126/science.289.5485.1757

10.1007/BF00308809

10.1007/978-3-7091-6467-9_11

Mirra, S. S. Neurobiol. Aging (1997) 4, S91-S94.